What happens to pharmaceuticals in the digestive system of a bird?

March 2, 2016, University of York

Scientists at the University of York have conducted new research into measuring how commonly-prescribed pharmaceuticals behave in the guts of starlings.

In a study led by Tom Bean, Professor Alistair Boxall and Dr Kathryn Arnold, from the University's Environment Department, researchers developed an in-vitro model (a laboratory-based system that avoids use of animal tests) to simulate the digestive system of a starling, recreating gastro-intestinal conditions that appear in real birds.

Worms containing fluoxetine - the active ingredient in antidepressant product Prozac - were fed to the in-vitro system to simulate birds feeding on worms and other invertebrates that have accumulated pharmaceuticals from and soils. Such contamination happens when sewage sludge is applied to land as a fertiliser.

Worms were also fed into an in-vitro model of the human gut to explore how Prozac, when introduced in worms, will behave in a bird gut compared to a human.

The researchers found that the drug behaved similarly in both the bird and human systems. Such results are invaluable in understanding how to use data detailing the effects of pharmaceuticals in humans, applying this across to wildlife species.

The study provides an important part of the toolkit for assessing the potential ecological risk when developing drugs, as little is currently known about the different ways in which pharmaceuticals can impact on wildlife.

Professor Boxall said: "There is increasing recognition that biologically active ingredients contained in pharmaceuticals could potentially affect wildlife, with fish and birds being prime candidates.

"Simulating starling ingestion of Prozac through prey, this research helps to bridge the gap between our knowledge of how drugs affect humans and how this translates to animals in the natural environment. Understanding what happens at different stages of the animal digestive process enables us to build a picture of wider environmental implications.

"With active drug ingredients often entering the environment indirectly through waste treatment systems, it is hoped that new test methods such as this, which do not involve testing on real animals, will be developed and used in the future for assessing the potential ecological impact of pharmaceuticals."

Tom Bean, PhD student and lead author of the project, said: "This study characterises the environmental impact that pharmaceuticals can have, paving the way for intelligence-led assessment in the development of new drugs."

Explore further: Experts offer new approach to prioritizing research on the environmental impacts of pharmaceuticals

More information: Thomas G. Bean et al. An method for determining the bioaccessibility of pharmaceuticals in wildlife , Environmental Toxicology and Chemistry (2016). DOI: 10.1002/etc.3406

Related Stories

Recommended for you

Study: With Twitter, race of the messenger matters

February 23, 2019

When NFL player Colin Kaepernick took a knee during the national anthem to protest police brutality and racial injustice, the ensuing debate took traditional and social media by storm. University of Kansas researchers have ...

After a reset, Сuriosity is operating normally

February 23, 2019

NASA's Curiosity rover is busy making new discoveries on Mars. The rover has been climbing Mount Sharp since 2014 and recently reached a clay region that may offer new clues about the ancient Martian environment's potential ...

Researchers engineer a tougher fiber

February 22, 2019

North Carolina State University researchers have developed a fiber that combines the elasticity of rubber with the strength of a metal, resulting in a tougher material that could be incorporated into soft robotics, packaging ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.